Gibberella intermedia CA3-1羟基化去氢表雄酮的工艺

利用Gibberella intermedia CA3-1对甾体化合物去氢表雄酮(DHEA)进行C7α-羟基化反应研究。用单因素实验的方法考察接种量、装液量、转速、有机溶剂助溶、投料浓度以及底物投加时间对产物7α-羟基去氢表雄酮(7α-OH-DHEA)生成的影响。最终确定最适工艺条件:接种量6%,装液量30 m L(250 m L三角瓶),转速220 r/min,体积分数6%丙二醇助溶,接种时即添加底物,底物DHEA质量浓度1 g/L,转化时间36 h。采用优化后的转化条件,7α-OH-DHEA摩尔得率为72.34%。     

细胞色素P450诱导剂对Gibberella intermedia CA3-1双羟化去氢表雄酮的影响

3β,7α,15α-三羟基雄甾-5-烯-17-酮(7α,15α-diOH-DHEA)是女用口服避孕药"优思明"主要成分屈螺酮的关键中间体。为了提高目的产物7α,15α-diOH-DHEA的摩尔得率,研究不同细胞色素P450酶(CYP450)诱导剂对Gibberella intermedia CA3-1转化去氢表雄酮(DHEA)生成7α,15α-diOH-DHEA生物转化过程的影响。结果发现:己烷、DHEA和苯可以显著提高7α,15α-diOH-DHEA的摩尔得率,其中苯是最佳诱导剂。在以上工作基础上,建立了如下的诱导过程:将进入对数生长期(接种后24 h)的种子液以10%的接种量接种到新鲜的转化培养基中,转化12 h后添加体积分数0.8%的苯进行诱导,然后在对数生长期结束时(转化24 h)将8 g/L的底物加入转化培养基进行转化。采用以上诱导条件,在5 L发酵罐中进行了生物转化。与不添加苯的工艺相比,CYP450的浓度提高了43%,7α,15α-diOH-DHEA的摩尔产率提高到68.7%±1.37%,同时转化周期缩短了8 h,这为7α,15α-diOH-DHEA的工业化生产奠定基础。     

1-辛基-3-甲基咪唑二氰铵盐/硫酸铵双水相体系分离纯化银杏黄酮

建立了由亲水性离子液体1-辛基-3-甲基咪唑二氰铵盐([C8mim][N(CN)2])和(NH4)2SO4形成的双水相萃取体系并应用于银杏黄酮的分离纯化研究。研究了盐浓度、体系温度、pH值、NaCl量等因素对银杏黄酮萃取效率的影响;并对下相中无机盐进行回收。体系由18.52%[C8mim][N(CN)2],25.93%(NH4)2SO4构成,加入1.5 mmol NaCl,在室温下进行萃取时萃取效率最佳,在最佳的条件下[C8mim][N(CN)2]/(NH4)2SO4体系对银杏黄酮的萃取效率达96.73%。与传统的双水相体系相比,该体系的萃取效率高,粘度低,同时(NH4)2SO4的回收率达90.54%。[C8mim][N(CN)2]/(NH4)2SO4双水相体系是一种很好的分离纯化银杏黄酮的方法。     

离子液体-微波辅助提取黄芩饮片中四种黄酮类成分(英文)

采用HPLC法建立黄芩饮片中黄芩苷、汉黄芩苷、黄芩素、汉黄芩素四种黄酮类化合物同时测定的方法;并且优选离子液体-微波辅助提取(IL-MAE)黄芩饮片中四种黄酮类成分的最佳工艺。优选的色谱分离条件为:Aglient TC-C18(250×4.6 mm,5.0μm)色谱柱,流动相为0.4%磷酸水(A)和甲醇(B),梯度洗脱程序为0~10min,40%~50%B;10~20 min,50%B;20~30 min,50%~60%B;30~40 min,60%~80%B;50 min,80%B,检测波长280 nm。优选的最佳的黄芩饮片IL-MAE条件为:以溴化-1-丁基-3-甲基咪唑盐为溶剂,固-液比为1∶100,提取时间为3 min,微波功率为264 W;将该工艺所得四种成分的含量与采用中国药典(2010版)所收载的"回流提取法"所得含量进行对比,IL-MAE显著地提高了黄芩饮片中四种黄酮类成分的含量并且缩短了提取时间。研究结果表明,所建立的HPLC分析方法灵敏、准确,可用于黄芩饮片的质量控制;所优选的黄芩饮片的IL-MAE简单,高效,快速,无污染。     

离子液体-微波辅助提取黄芩饮片中四种黄酮类成分(英文)北大核心CSCD

采用HPLC法建立黄芩饮片中黄芩苷、汉黄芩苷、黄芩素、汉黄芩素四种黄酮类化合物同时测定的方法;并且优选离子液体-微波辅助提取（IL-MAE）黄芩饮片中四种黄酮类成分的最佳工艺。优选的色谱分离条件为：Aglient TC-C18（250×4.6 mm,5.0μm）色谱柱,流动相为0.4%磷酸水（A）和甲醇（B）,梯度洗脱程序为0-10min,40%-50%B;10-20 min,50%B;20-30 min,50%-60%B;30-40 min,60%-80%B;50 min,80%B,检测波长280 nm。优选的最佳的黄芩饮片IL-MAE条件为：以溴化-1-丁基-3-甲基咪唑盐为溶剂,固-液比为1∶100,提取时间为3 min,微波功率为264 W;将该工艺所得四种成分的含量与采用中国药典（2010版）所收载的＂回流提取法＂所得含量进行对比,IL-MAE显著地提高了黄芩饮片中四种黄酮类成分的含量并且缩短了提取时间。研究结果表明,所建立的HPLC分析方法灵敏、准确,可用于黄芩饮片的质量控制;所优选的黄芩饮片的IL-MAE简单,高效,快速,无污染。     

分子佐剂C3d上调Raji细胞协同刺激分子B7-1和B7-2的表达(简报)

我们在以往研究中,引入选择性增强体液免疫效应的新型分子佐剂C3d,成功构建了重组避孕疫苗hCGB-C3d3,通过免疫Th2型优势的 BALB/c小鼠和,Th1型优势的C57BL/6小鼠,显示分子佐剂C3d在不同品系小鼠均使免疫效应从Th1型细胞免疫向Th2型体液免疫偏倚。     

用聚乙二醇(PEG)／无机盐双水相体系从枯草杆菌发酵液中提取a-淀粉酶的研究

本文报道分别用聚乙二醇(PEG)／磷酸盐和PEG／(NH·)2SO4双水相体系从枯草轩菌发酵液中提取a-淀粉酶。研究了PEG的平均分子量、PEG浓度,成相的盐的浓度和Nacl的浓度对a-淀粉酶和蛋白质的分配系数以及相比的影响,确定了最佳的操作条件。实验表明在180%PEG 1500／10％磷酸盐／0．05M NaCl的体系中,a-淀粉酶的分配系数为6.62,蛋白质分配系数为1．14,相比为2．5,a-淀粉酶总收率为94．3％,在16％PEG 1500／12％(NH₄)₂SO₄／O．05M NaCl体系中,a-淀粉酶分配系数为82,蛋白质分配系数为5．2,相比为O．92,酶收率为99％,结果表明用PEG／无机盐双水相体系直接从含有菌体的发酵液中提取a-淀粉酶是可行的。     

强啡肽A_(1-13)对谷氨酸诱导的大鼠C6胶质瘤细胞肿胀的影响

目的和方法 :探讨脑水肿发病的细胞机制 ,采用 [3H]OMG摄取的方法测定细胞含水量 ,观察DynA对谷氨酸诱导的大鼠C6胶质瘤细胞肿胀的影响。结果 :①给予 0 .5 ,1.0 ,10 .0mmol/L的谷氨酸作用 1h均可引起细胞的含水量增加 ;②DynA可显著降低谷氨酸诱导肿胀的大鼠C6胶质瘤细胞含水量 ;③κ阿片受体拮抗剂nor BNI可阻断DynA1-13 降低谷氨酸诱导肿胀的大鼠C6胶质瘤细胞含水量的作用。结论 :谷氨酸可诱导大鼠C6胶质瘤细胞肿胀 ;DynA1-13 可通过激活κ阿片受体抑制谷氨酸诱导的大鼠C6胶质瘤细胞肿胀     

邻单胞菌邻苯二酚1,2-双加氧酶基因(tfd C)的克隆及其在大肠杆菌中表达

根据已报道的邻苯二酚１,２－双加氧酶基因（ｔｆｄ Ｃ）序列,设计ＰＣＲ引物,从一株邻单胞菌（Ｐｌｅｓｉｏｍｉｎａｓ）的ｐＬ１质粒上扩增到ｔｆｄ Ｃ基因片段,连接到ｐＧＥＭ－Ｔ载体上,并转化大肠杆菌ｌＭ１０９菌株,筛选到阳性克隆。序列分析结果表明,ＰＣＲ产物全长８０１ｂｐ,有一阅读框,编码２５５个氨基酸,与增氧产碱菌（Ａｌｃａｌｉｇｅｎｅｓ ｅｕｔｒｏｐｌｕｓ）的ｔｆｄ Ｃ基因相比,在６９３位相差一     

Gibberella intermedia C2转化4-雄甾烯-3、17-二酮的研究

甾体化合物具有独特的生理活性,已被广泛应用于抗炎、利尿、免疫、避孕及抗癌等领域。近些年,生物催化与转化在甾体药物中间体合成中发挥的作用日益强大。为了能够合成一些具有潜在价值的新型甾体化合物,以实验室菌种库中保藏的一株Gibberella intermedia C2为研究对象,选取了雄甾烷中一种有广泛用途的化合物4-雄甾烯-3、17-二酮(简称雄烯二酮,AD)为底物进行生物转化。转化液经提取分离,最终获得2个转化产物,经结构鉴定分别为15α-OH-AD和11α,15α-diOH-AD。转化机制研究发现,G.intermedia C2先将底物的15位羟基化生成15α-OHAD,再将其11位羟基化形成双羟基产物。赤霉菌能够特异性、有序地完成对AD的两步羟化反应。此外,通过工艺优化,确定了羟化4AD反应的最适工艺参数如下:发酵培养基的初始pH 6.5,装液量30ml/250ml,底物浓度6.0g/L,转化温度28℃,摇床转速220r/min,转化周期为84h。此时,底物AD的摩尔转化率达到81.5%。     

In vivo activation of the constitutive androstane receptor beta (CARbeta) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA-S)

We investigated whether dehydroepiandrosterone (DHEA) or DHEA-sulfate (S) affected the activities of nuclear receptors, with special reference to constitutive androstane receptor beta (CARbeta). Administration of DHEA or DHEA-S enhanced the DNA binding of hepatic nuclear extracts to responsive elements for the retinoic acid receptor, the retinoic acid receptor beta 2 and the peroxisome proliferator activated receptor. The bound complexes were shown to be the CARbeta-RXR heterodimer by antibody-supershift assays. The expression of a target gene of CARbeta, Cyp2b10, was increased in liver by DHEA or DHEA-S treatment, suggesting that DHEA or DHEA-S actually activated CARbeta in vivo. It was suggested that the metabolic conversion of DHEA, DHEA-S to CARbeta ligands could occur in vivo and the metabolites could regulate the expression of CARbeta target gene expression. Our results provide new insights into the in vivo relationship between DHEA/DHEA-S and CARbeta activation.     

Investigation of behavior of an enzyme in a biphasic system: soybean lipoxygenase-1

Soybean lipoxygenase-1 (EC 1.13.11.12) reaction with linoleic acid as substrate was used to study the biocatalysis in a biphasic system when the reactants have surface-active properties. The poorly water-soluble substrate was initially dissolved in an apolar solvent (octane). The hydroperoxide produced was water soluble and remained in the aqueous phase (borate buffer). The bioreactor was a modified Lewis cell with a well-defined interfacial area between the two phases. Two phenomena were studied separately: the reactant transfer between the two phases and the biocatalyzed reaction in an aqueous medium. This allowed determination of the transfer and the reaction constants. Substrate transfer was found to be affected by the progress of the reaction, because linoleic acid and the hydroperoxy acid have an influence on the interfacial tension. Inactivation of the biocatalyst at the interface was observed in the bioreactor. These results indicate that it is impossible to analyze the system behavior with the method proposed in the literature, which is based on the sequential study of the substrate transfer to the aqueous phase and its biocatalysis by lipoxygenase. The interaction between transfer phenomena and reaction kinetics was studied in the biphasic system. The kinetics were different from those obtained in the aqueous medium. Catalysis and transfer influence each other reciprocally. In this compartmentalized system, cooperativity phenomena were obtained using a nonallosteric enzyme. The evolution of the system was modeled (Runge-Kutta algorithm). The curves obtained were very close to those determined experimentally.     

Efficient anti-Prelog enantioselective reduction of acetyltrimethylsilane to (R)-1-trimethylsilylethanol by immobilized Candida parapsilosis CCTCC M203011 cells in ionic liquid-based biphasic systems

ABSTRACT: BACKGROUND: Biocatalytic asymmetric reductions with whole cells can offer high enantioselectivity, environmentally benign processes and energy-effective operations and thus are of great interest. The application of whole cell-mediated bioreduction is often restricted if substrate and product have low water solubility and/or high toxicity to the biocatalyst. Many studies have shown that a biphasic system is often useful in this instance. Hence, we developed efficient biphasic reaction systems with biocompatible water-immiscible ionic liquids (ILs), to improve the biocatalytic anti-Prelog enantioselective reduction of acetyltrimethylsilane (ATMS) to (R)-1-trimethylsilylethanol {(R)-1-TMSE}, which is key synthon for a large number of silicon-containing drugs, using immobilized Candida parapsilosis CCTCC M203011 cells as the biocatalyst. RESULTS: It was found that the substrate ATMS and the product 1-TMSE exerted pronounced toxicity to immobilized Candida parapsilosis CCTCC M203011 cells. The biocompatible water-immiscible ILs can be applied as a substrate reservoir and in situ extractant for the product, thus greatly enhancing the efficiency of the biocatalytic process and the operational stability of the cells as compared to the IL-free aqueous system. Various ILs exerted significant but different effects on the bioreduction and the performances of biocatalysts were closely related to the kinds and combination of cation and anion of ILs. Among all the water-immiscible ILs investigated, the best results were observed in 1-butyl-3-methylimidazolium hexafluorophosphate (C4mim * PF6)/buffer biphasic system. Furthermore, it was shown that the optimum substrate concentration, volume ratio of buffer to IL, buffer pH, reaction temperature and shaking rate for the bioreduction were 120 mM, 8/1 (v/v), 6.0, 30 degreesC and 180 r/min, respectively. Under these optimized conditions, the initial reaction rate, the maximum yield and the product e.e. were 8.1 mumol/min gcwm, 98.6 % and >99 %, respectively. The efficient whole-cell biocatalytic process was shown to be feasible on a 450-mL scale. Moreover, the immobilized cells remained around 87 % of their initial activity even after being used repeatedly for 8 batches in the C4mim * PF6/buffer biphasic system, exhibiting excellent operational stability. CONCLUSIONS: For the first time, we have successfully utilized immobilized Candida parapsilosis CCTCC M203011 cells, for efficiently catalyzing anti-Prelog enantioselective reduction of ATMS to enantiopure (R)-1-TMSE in the C4mim * PF6/buffer biphasic system. The substantially improved biocatalytic process appears to be effective and competitive on a preparative scale.     

Chemoprevention of precursors to colon cancer by dehydroepiandrosterone (DHEA)

Although dehydroepiandrosterone (DHEA) is recognized as one of the major adrenal androgens, its precise physiological role in the human endocrine system remains to be elucidated. In particular, the effect of DHEA on carcinogenesis has not been fully characterized. We undertook this study to determine whether DHEA has a chemopreventative effect on the precursors of colon cancer in a murine model of azoxymethane (AOM)-induced aberrant crypt foci (ACF). The number of ACF was significantly decreased in mice treated with 0.4% (p < 0.001) and 0.8% DHEA (p < 0.001), but there were no significant differences between DHEA-treated and control mice in terms of the ACF size, 3-catenin expression or level of dysplasia. This is the first study of colon cancer carcinogenesis demonstrating that DHEA treatment can decrease the number of ACF without apparently modifying their malignant potential. These data strongly suggest that DHEA might be a potential chemopreventative agent against human colon cancer.     

Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)

Background

Exposure of pregnant mothers to elevated concentrations of circulating testosterone levels is associated with fetal growth restriction and delivery of small-for-gestational-age babies. We examined whether maternal testosterone crosses the placenta to directly suppress fetal growth or if it modifies placental function to reduce the capacity for transport of nutrients to the fetus.

Methods

Pregnant rats were exposed to testosterone propionate (TP; 0.5 mg/kg) by daily subcutaneous injection from gestational days (GD) 15-19. Maternal and fetal testosterone levels, placental nutrient transport activity and expression of transporters and birth weight of pups and their anogenital distances were determined.

Results

This dose of TP doubled maternal testosterone levels but had no effect on fetal testosterone levels. Maternal daily weight gain was significantly lower only on GD 19 in TP treated dams compared to controls. Placental weight and birth weight of pups were significantly reduced, but the anogenital distance of pups were unaffected by TP treatment. Maternal plasma amino acids concentrations were altered following testosterone exposure, with decreases in glutamine, glycine, tyrosine, serine, proline, and hydroxyproline and increases in asparagine, isoleucine, leucine, lysine, histidine and arginine. In the TP dams, placental system A amino acid transport activity was significantly reduced while placental glucose transport capacity was unaffected. Decreased expression of mRNA and protein levels of slc38a2/Snat2, an amino acid transporter, suggests that reduced transporter proteins may be responsible for the decrease in amino acid transport activity.

Conclusions

Taken together, these data suggest that increased maternal testosterone concentrations do not cross the placenta to directly suppress fetal growth but affects amino acid nutrient delivery to the fetus by downregulating specific amino acid transporter activity.     

Enhancements of enantio and diastereoselectivities in reduction of (Z)-3-halo-4-phenyl-3-buten-2-one mediated by microorganisms in ionic liquid/water biphasic system

Reductions of (Z)-C₆H₅CHCXC(O)CH₃ (X = Cl, Br) mediated by Saccharomyces cerevisiae, Candida albicans, Rhodotorula glutinis, Geotrichum candidum and Micrococcus luteus gave the corresponding halohydrins through consecutive reduction reactions of CC and CO bonds. In general, the reactions performed in the biphasic system water/[(bmim)PF₆] gave better diastereoselectivity and enantioselectivity than in pure water.     

Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response

The acute-phase response (APR) induces alterations in lipid metabolism, and our data suggest that this is associated with suppression of type II nuclear hormone receptors that are key regulators of fatty acid, cholesterol, and bile acid metabolism. Recently, the farnesoid X receptor (FXR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR) were found to regulate DHEA sulfotransferase (Sult2A1), which plays an important role in DHEA sulfation and detoxification of bile acids. Because FXR, PXR, and CAR are suppressed during the APR, we hypothesized that Sult2A1 is downregulated during the APR. To induce the APR, mice were treated with LPS, which will then trigger the release of various cytokines, and the mRNA levels of Sult2A1 and the sulfate donor 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2), as well as the enzyme activity of Sult2A1, were determined in the liver. We found that mRNA levels of Sult2A1 decrease in a time- and dose-dependent manner during the LPS-induced APR. Similar changes were observed in the mRNA levels of PAPSS2, the major synthase of PAPS in the liver. Moreover, hepatic Sult2A1 activity and serum levels of DHEA-sulfate (DHEA-S) were significantly decreased in LPS-treated animals. These results suggest that decreased levels or activities of FXR, PXR, and CAR during the APR could contribute to decreases in Sult2A1, resulting in decreased sulfation of DHEA and lower circulating level of DHEA-S. Finally, we found that both TNF and IL-1 caused a significant decrease in the mRNA level of Sult2A1 in Hep3B human hepatoma cells, suggesting that the proinflammatory cytokines TNF and IL-1 mediate the inhibitory effect of LPS on Sult2A1 mRNA level. Our study provides a possible mechanism by which infection and inflammation are associated with altered steroid metabolism and cholestasis.